A Path to Improved Alzheimer’s Care: Simulating Long-Term Health Outcomes of Lecanemab in Early Alzheimer’s Disease from the CLARITY AD Trial
Crossref DOI link: https://doi.org/10.1007/s40120-023-00473-w
Published Online: 2023-04-02
Published Print: 2023-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tahami Monfared, Amir Abbas https://orcid.org/0000-0003-4003-3192
Ye, Weicheng
Sardesai, Aditya
Folse, Henri
Chavan, Ameya
Aruffo, Elena
Zhang, Quanwu
Text and Data Mining valid from 2023-04-02
Version of Record valid from 2023-04-02
Article History
Received: 3 February 2023
Accepted: 21 March 2023
First Online: 2 April 2023